Epidermal growth factor receptor regulates fibrinolytic pathway elements in cervical cancer: functional and prognostic implications

Epidermal growth factor receptor regulates fibrinolytic pathway elements in cervical cancer: functional and prognostic implications

Epidermal growth factor receptor (EGFR) signaling and components of the fibrinolytic system, including urokinase-type plasminogen activator (uPA) and thrombomodulin (TM), have been implicated in tumor progression. In the present study, we employed cBioPortal platform (http://www.cbioportal.org/), ca...

Full description

Bibliographic Details
Main Authors:	F.G. Gomes, V.H. Almeida, K. Martins-Cardoso, M.M.D.C. Martins-Dinis, A.M.R. Rondon, A.C. de Melo, T.M. Tilli, R.Q. Monteiro
Format:	Article
Language:	English
Published:	Associação Brasileira de Divulgação Científica
Series:	Brazilian Journal of Medical and Biological Research
Subjects:	Cervical cancer Epidermal growth factor receptor Urokinase-type plasminogen activator Thrombomodulin Fibrinolytic system
Online Access:	http://www.scielo.br/pdf/bjmbr/v54n6/1414-431X-bjmbr-54-6-e10754.pdf

Similar Items

Fibrinolytics: from the thrombolysis to the processes of blood vessels growth and remodeling, neurogenesis, carcinogenesis and fibrosis
by: V A Tkachuk, et al.
Published: (2019-09-01)

A study of the interaction between Helicobacter pylori and components of the human fibrinolytic system
by: A. Yarzábal, et al.
Published: (2000-09-01)

Decrease of fibrinolytic potential in the occurrence of cerebral ischemia
by: Vučković Biljana, et al.
Published: (2008-01-01)

Role of Fibrinolytic Enzymes in Anti-Thrombosis Therapy
by: Farwa Altaf, et al.
Published: (2021-05-01)

Fibrinolysis versus thoracoscopy: Comparison of results in empyema management in the child
by: Maria Rosa Ibarra Rodriguez, et al.
Published: (2022-01-01)

A fatal case of traumatic brain injury with severe coagulopathy due to Rhabdophis tigrinus (yamakagashi) bites: a case report
by: Daisuke Ueno, et al.
Published: (2021-12-01)

Precision targeting of the plasminogen activator inhibitor‐1 mechanism increases efficacy of fibrinolytic therapy in empyema
by: Galina Florova, et al.
Published: (2021-05-01)

Intrapleural Instillation of Sodium Bicarbonate versus Urokinase in Management of Complicated Pleural Effusion: A Comparative Cohort Study
by: Zayed NE, et al.
Published: (2022-12-01)

Intrapleural Fibrinolysis in Post-tubercular Loculated Pleural Effusions at a Tertiary-Care Respiratory Center: An Uncontrolled Blinded Before-After Intervention Study
by: Narayanan Subramanian, et al.
Published: (2018-04-01)

In Vitro Study of the Fibrinolytic Activity via Single Chain Urokinase-Type Plasminogen Activator and Molecular Docking of FGFC1
by: Chunli Gao, et al.
Published: (2021-03-01)

Predicting Mortality in African Americans With Type 2 Diabetes Mellitus: Soluble Urokinase Plasminogen Activator Receptor, Coronary Artery Calcium, and High‐Sensitivity C‐Reactive Protein
by: Salim S. Hayek, et al.
Published: (2018-05-01)

Value of soluble Urokinase plasminogen activator receptor over age as a biomarker of impaired myocardial relaxation
by: Koh, Angela S., et al.
Published: (2018)

Fibrin and Fibrinolytic Enzyme Cascade in Thrombosis: Unravelling the Role
by: Rajni Singh, et al.
Published: (2023-11-01)

Pro-fibrinolytic potential of the third larval stage of Ascaris suum as a possible mechanism facilitating its migration through the host tissues
by: Alicia Diosdado, et al.
Published: (2020-04-01)

Urokinase-type plasminogen activator is a modulator of synaptic plasticity in the central nervous system: implications for neurorepair in the ischemic brain
by: Manuel Yepes
Published: (2020-01-01)

Role of Plasminogen Activation System in Platelet Pathophysiology: Emerging Concepts for Translational Applications
by: Filomena Napolitano, et al.
Published: (2022-05-01)

Activación y determinación de parámetros cinéticos de la Plasmina Humana y Ovis aries
by: Omaira Cañas, et al.
Published: (2011-01-01)

Evaluation of Urokinase Plasminogen Activator Receptor, Soluble Urokinase Plasminogen Activator Receptor, and β1 Integrin in Patients with Hodgkin′s Lymphoma
by: Shirin Kouhpayeh, et al.
Published: (2017-01-01)

Laboratory evaluation of a new integrative assay to phenotype plasma fibrinolytic system
by: Marion Bareille, et al.
Published: (2022-12-01)

The use of combination of fibrinolytic therapy and abciximab in the treatment of the acute myocardial infarction with ST elevation
by: Gligić Branko, et al.
Published: (2002-01-01)

Fibrinolysis protease receptors promote activation of astrocytes to express pro-inflammatory cytokines
by: Paola Pontecorvi, et al.
Published: (2019-12-01)

Food Origin Fibrinolytic Enzyme With Multiple Actions
by: Laurentia Stephani, et al.
Published: (2018-03-01)

Food Origin Fibrinolytic Enzyme With Multiple Actions
by: Laurentia Stephani, et al.
Published: (2017-07-01)

The Contribution of the Urokinase Plasminogen Activator and the Urokinase Receptor to Pleural and Parenchymal Lung Injury and Repair: A Narrative Review
by: Torry A. Tucker, et al.
Published: (2021-02-01)

Fibrinolysis regulation by platelets retaining plasminogen and tissue-type plasminogen activator on their surface
by: T. Grinenko, et al.
Published: (2019-12-01)

Urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type-1 (PAI-1) in breast cancer - correlation with traditional prognostic factors
by: Lampelj Maja, et al.
Published: (2015-12-01)

Perspective on fibrinolytic therapy in COVID-19: the potential of inhalation therapy against suppressed-fibrinolytic-type DIC
by: Hidesaku Asakura, et al.
Published: (2020-09-01)

Fibrinolytic activity of Amirkabiria odoratissima Mozaffarian
by: S Asgary, et al.
Published: (2005-02-01)

Reduced Expression of Urokinase Plasminogen Activator in Brown Adipose Tissue of Obese Mouse Models
by: Chung-Ze Wu, et al.
Published: (2021-03-01)

Macrophages and Urokinase Plasminogen Activator Receptor System in Multiple Myeloma: Case Series and Literature Review
by: Paola Manzo, et al.
Published: (2023-06-01)

Serum Levels of Urokinase Plasminogen Activator Receptor (suPAR) Discriminate Moderate Uncontrolled from Severe Asthma
by: Ourania S. Kotsiou, et al.
Published: (2022-10-01)

Inhibitory effects of wogonin on invasion by human oral cancer cells by decreasing the activity of matrix metalloproteinases and urokinase-plasminogen activator
by: Yung-Chuan Ho, et al.
Published: (2014-06-01)

Specific inhibitors of urokinase plasminogen activator for treatment of cancers; In silico approach
by: Benjamin Talbot, et al.
Published: (2020-05-01)

Concentrations of plasminogen activator inhibitor-1 (PAI-1) and urokinase plasminogen activator (uPA) in induced sputum of asthma patients after allergen challenge
by: Krzysztof Kowal,, et al.
Published: (2010-04-01)

Identification and characterization of fibrinolytic enzyme producing bacteria isolated from shrimp paste /
by: Abir Mabruk M.Benashur, 1982-, et al.
Published: (2011)

Identification and characterization of fibrinolytic enzyme producing bacteria isolated from shrimp paste [electronic resource] /
by: Abir Mabruk M.Benashur, 1982-
Published: (2011)

The use of fibrinolytic therapy for parapneumonic effusion in pregnancy: a case report and a review
by: Awrad Nasralla, et al.
Published: (2021-08-01)

Soluble Urokinase Plasminogen Activator Receptor (suPAR) in the Emergency Department (Ed): A Tool for the Assessment of Elderly Patients
by: Ria M. Holstein, et al.
Published: (2022-06-01)

Fibrin γ/γ' influences the secretion of fibrinolytic components and clot structure
by: Miriam Cantero, et al.
Published: (2019-11-01)

Immunohistochemical study of the plasminogen activator system in benign epithelial odontogenic lesions
by: Carla Samily de Oliveira Costa, et al.
Published: (2022-05-01)